Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| ALLIANCE FIB | AFOP | 11.15% |
| SONIC FOUNDR | SOFO | 8.21% |
| NOAH HOLDING | NOAH | 7.85% |
| TRI TECH HOL | TRIT | 6.63% |
| A M R CP | AAMRQ | 4.71% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
In an effort to extend the services of ferrous derivatives contracts, CME Group Inc. ( CME - Analyst Report ) plans to launch a U.S. steel scrap contract in autumn, Reuters reported this Wednesday. Also, the Chicago exchange plans to capitalize on the increasing interest in price risk management in this emerging sector.
The contracts are scheduled to be settled against the AMM Index, in cash terms. This will be the second scrap contract and the 13th steel and steel raw material contract for the company. Many financial institutions have shown interest in the contract, noteworthy among them being J. P. Morgan, a division of JPMorgan Chase & Co. ( JPM - Analyst Report ) .
Scrap recyclers, small mills and construction companies that purchase long steel products for manufacturing can explore hedging opportunities from CME Group’s expansion. Also, the recent fall in interest in the four-year old steel physically-backed billet futures, an offering of the London Metal Exchange, can prove advantageous for the company.
The news comes on the heels of the company’s continuous efforts to launch ferrous contracts in China, which is a promising market for steel products owing to its rapidly increasing investor base. CME Group is striving to tap the opportunities available in the emerging markets of Asia. It is working closely with MySteel, which is assisting the company in accumulating pricing data which will be used for an expected contract.
In spite of the efforts initiated by CME Group to improve its position amidst the ongoing weakness in the derivative markets, the widening of spreads continues to hamper both its top line and earnings. The near-term outlook looks grim and may continue to dampen the company’s operating leverage until the derivative markets gain traction.
CME Group currently retains a Zacks #5 Rank, which translates into a short-term Strong Sell rating. We are also maintaining our long-term Underperform recommendation on the shares.
Read the full Analyst Report on CME
Read the full Analyst Report on JPM